SYRE’s Innovative Biologics: A Game-Changer in Inflammatory Bowel Disease Treatment
Targeting Leading IBD Pathways, SYRE Aims to Redefine Efficacy and Convenience with Next-Generation Antibodies SYRE (SYRE), a clinical-stage biopharmaceutical company, ...


















